Form 4: Climb Bio Insider Reports Stock Transaction
Insider Transaction (Form 4)
Ra Capital Management, L.P. and 6 others reported changes in beneficial ownership of Climb Bio, Inc. common stock on September 28, 2026.
Summary
- Option exercise/conversion: acquired 10,000 Common Stock at $3.46 ($34,600) on September 28, 2026; holds 10,000 after (Indirect).
- Option exercise/conversion: acquired 10,000 Common Stock at $3.00 ($30,000) on September 28, 2026; holds 20,000 after (Indirect).
- Option exercise/conversion: acquired 10,000 Common Stock at $7.89 ($78,900) on September 28, 2026; holds 30,000 after (Indirect).
- Option exercise/conversion: acquired 40,000 Common Stock at $1.29 ($51,600) on September 28, 2026; holds 70,000 after (Indirect).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 28, 2026 (Indirect).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 28, 2026 (Indirect).
- Option exercise/conversion: disposed of 10,000 Stock Option (Right to Buy) on September 28, 2026 (Indirect).
- Option exercise/conversion: disposed of 40,000 Stock Option (Right to Buy) on September 28, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ra Capital Management, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
RA Capital Nexus Fund II, L.P. — Director
RA Capital Nexus Fund III, L.P. — Director
Peter Kolchinsky — Director, 10% owner
Rajeev M. Shah — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Option exercise/conversion | Common Stock | 10,000 | $3 | $34.6K | 10,000 |
| 2026-09-28 | Option exercise/conversion | Common Stock | 10,000 | $3 | $30.0K | 20,000 |
| 2026-09-28 | Option exercise/conversion | Common Stock | 10,000 | $8 | $78.9K | 30,000 |
| 2026-09-28 | Option exercise/conversion | Common Stock | 40,000 | $1 | $51.6K | 70,000 |
| 2026-09-28 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 0 |
| 2026-09-28 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 0 |
| 2026-09-28 | Option exercise/conversion | Stock Option (Right to Buy) | 10,000 | — | — | 0 |
| 2026-09-28 | Option exercise/conversion | Stock Option (Right to Buy) | 40,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (40,000 shares) |
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (10,000 shares) |
| 2026-09-28 | Option exercise/conversion (40,000 shares) |
Keywords
insider transaction, Form 4, CLYM, Climb Bio, Inc., neutral, Ra Capital Management, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., RA Capital Nexus Fund III, L.P., Peter Kolchinsky, Rajeev M. Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.